BRCA1 and ovarian neoplasm: We also found that PARP1 sgRNA caused PARPi resistance in BRCA1 mutant COV362 ovarian tumour cells34 (BRCA1 c.2611fs [exon 11] and c.4095+1G>T [exon 11 splice donor]), suggesting that these observations were not private to SUM149 cells.